TCT-104 Relative Efficacy and Safety of oral P2Y12 inhibitors in Acute coronary syndrome: An Updated Network Meta-Analysis of Randomized Trials

A Class 1 indication for patients with acute coronary syndrome (ACS) is dual antiplatelet inhibitors therapy (DAPT) including aspirin and a P2Y12 inhibitor. Randomized controlled trials (RCTs) have shown prasugrel and ticagrelor are superior to clopidogrel, but no RCT has directly compared these